{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361981470204697984.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1056/nejmoa0806182"}},{"identifier":{"@type":"URI","@value":"http://www.nejm.org/doi/pdf/10.1056/NEJMoa0806182"}}],"dc:title":[{"@value":"Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381981470204697990","@type":"Researcher","foaf:name":[{"@value":"Kenneth Jamerson"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981470204697988","@type":"Researcher","foaf:name":[{"@value":"Michael A. Weber"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981470204697991","@type":"Researcher","foaf:name":[{"@value":"George L. Bakris"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981470204697857","@type":"Researcher","foaf:name":[{"@value":"Björn Dahlöf"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981470204697985","@type":"Researcher","foaf:name":[{"@value":"Bertram Pitt"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981470204697986","@type":"Researcher","foaf:name":[{"@value":"Victor Shi"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981470204697989","@type":"Researcher","foaf:name":[{"@value":"Allen Hester"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981470204697987","@type":"Researcher","foaf:name":[{"@value":"Jitendra Gupte"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981470204697856","@type":"Researcher","foaf:name":[{"@value":"Marjorie Gatlin"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981470204697984","@type":"Researcher","foaf:name":[{"@value":"Eric J. Velazquez"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00284793"},{"@type":"EISSN","@value":"15334406"},{"@type":"PISSN","@value":"https://id.crossref.org/issn/00284793"}],"prism:publicationName":[{"@value":"New England Journal of Medicine"}],"dc:publisher":[{"@value":"Massachusetts Medical Society"}],"prism:publicationDate":"2008-12-04","prism:volume":"359","prism:number":"23","prism:startingPage":"2417","prism:endingPage":"2428"},"reviewed":"false","url":[{"@id":"http://www.nejm.org/doi/pdf/10.1056/NEJMoa0806182"}],"createdAt":"2008-12-03","modifiedAt":"2017-06-18","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050001338813734400","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"The clinical relevance of plasma CD147/basigin in biopsy-proven kidney diseases"}]},{"@id":"https://cir.nii.ac.jp/crid/1050013397240361344","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Calcium channel blocker in patients with chronic kidney disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360002219756254464","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Five-Year Prognosis After Endovascular Therapy in Claudicant Patients With Iliofemoral Artery Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004233405781632","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Azelnidipine attenuates glomerular damage in Dahl salt-sensitive rats by suppressing sympathetic nerve activity"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004233405963008","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004233406330368","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Sex differences in response to angiotensin II receptor blocker-based therapy in elderly, high-risk, hypertensive Japanese patients: a subanalysis of the OSCAR study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004233413039744","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"An angiotensin II receptor blocker–calcium channel blocker combination prevents cardiovascular events in elderly high-risk hypertensive patients with chronic kidney disease better than high-dose angiotensin II receptor blockade alone"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004237535889536","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Calcium Channel Blocker Enhances Beneficial Effects of an Angiotensin II AT1 Receptor Blocker against Cerebrovascular-Renal Injury in type 2 Diabetic Mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1360005518347767040","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)"}]},{"@id":"https://cir.nii.ac.jp/crid/1360005521464389120","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Thiazide Use and Cardiovascular Events in Type 2 Diabetic Patients With Well-Controlled Blood Pressure"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285706934448256","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Angiotensin II Receptor Blocker-based Therapy in Japanese Elderly, High-risk, Hypertensive Patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285707221213696","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Differential blood pressure reductions by angiotensin receptor blocker plus calcium channel blocker or diuretic in elderly hypertension with or without obesity"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285707221220096","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Effects of antihypertensive treatment in Asian populations: A meta-analysis of prospective randomized controlled studies (CARdiovascular protectioN group in Asia: CARNA)"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285708382319488","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Comparison of combination therapies, including the angiotensin receptor blocker olmesartan and either a calcium channel blocker or a thiazide diuretic, in elderly patients with hypertension"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285708382481920","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Optimal Combination of Effective ANtihypertensives (OCEAN) study: a prospective, randomized, open-label, blinded endpoint trial—rationale, design and results of a pilot study in Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285708382592256","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Comparison of medium-dose losartan/hydrochlorothiazide and maximal-dose angiotensin II receptor blockers in the treatment of Japanese patients with uncontrolled hypertension: the Kobe-CONNECT Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285708382829056","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Effect of tablets with a combination of telmisartan and amlodipine on patients with hypertension: the Cotalo study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285709874024960","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Comparison of telmisartan/amlodipine and telmisartan/hydrochlorothiazide in the treatment of Japanese patients with uncontrolled hypertension"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285712480246144","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Calcium Channel Blockers, More than Diuretics, Enhance Vascular Protective Effects of Angiotensin Receptor Blockers in Salt-Loaded Hypertensive Rats"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285714188746880","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Relationship of Ambulatory Blood Pressure and the Heart Rate Profile with Renal Function Parameters in Hypertensive Patients with Chronic Kidney Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360564064060480896","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Safety and clinical outcome in combination therapy for high-risk elderly hypertensive patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565170463899776","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Beneficial Effect of Switching from a Combination of Angiotensin II Receptor Blockers other than Losartan and Thiazides to a Fixed Dose of Losartan/Hydrochlorothiazide on Uric Acid Metabolism in Hypertensive Patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567181289200128","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Design and Rationale of Japanese Evaluation Between Formula of Azelnidipine and Amlodipine Add on Olmesartan to Get Antialbuminuric Effect Study (J-FLAG)"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567182197920128","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Differential effects of strict blood pressure lowering by losartan/hydrochlorothiazide combination therapy and high-dose amlodipine monotherapy on microalbuminuria: the ALPHABET study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567183347390336","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Amlodipine enhances amelioration of vascular insulin resistance, oxidative stress, and metabolic disorders by candesartan in metabolic syndrome rats"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567184628148096","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Kidney-protective effects of azelnidipine versus a diuretic in combination with olmesartan in hypertensive patients with diabetes and albuminuria: a randomized study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567184843969024","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Combination of antihypertensive therapy in the elderly, multicenter investigation (CAMUI) trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567184849893760","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Choice of Antihypertensive Combination Therapy Based on Daily Salt Intake"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567189165434880","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Effects of Multiple Factorial Intervention on Ambulatory BP Profile and Renal Function in Hypertensive Type 2 Diabetic Patients with Overt Nephropathy – A Pilot Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846643661415680","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Combined Effect of Angiotensin II Receptor Blocker and Either a Calcium Channel Blocker or Diuretic on Day-by-Day Variability of Home Blood Pressure"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848654995753856","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Beneficial Cardiometabolic Actions of Telmisartan Plus Amlodipine Therapy in Elderly Patients With Poorly Controlled Hypertension"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848656494797312","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Evidence-based practice guideline for the treatment for diabetes in Japan 2013"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848658336434816","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Therapeutic impact of the single fixed-dose combination with a high-dose angiotensin-receptor blocker and a low-dose thiazide diuretic in the management of hypertension: awaiting further accumulation of clinical evidence"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848659820603904","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Prevention of cardiovascular events with calcium channel blocker-based combination therapies in patients with hypertension"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848659820641792","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The velocity of antihypertensive effect of losartan/hydrochlorothiazide and angiotensin II receptor blocker"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848661366640512","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Consensus Document on Improving Hypertension Management in Asian Patients, Taking Into Account Asian Characteristics"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848662967729920","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Fixed-dose combination therapy of candesartan cilexetil and amlodipine besilate for the treatment of hypertension in Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567474843392","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Thiazide Use and Decreased Risk of Heart Failure in Nondiabetic Patients Receiving Intensive Blood Pressure Treatment"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567674060416","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Comparison of effects of L/N‐type and L‐type calcium channel blockers on post‐infarct cardiac remodelling in spontaneously hypertensive rats"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204274706176","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Combination therapy for hypertensive patients: end-organ protection by combination of ARB and CCB"},{"@language":"ja","@value":"高血圧治療薬の併用療法：ARBとCCB併用による臓器保護効果"},{"@language":"ja-Kana","@value":"コウケツアツ チリョウヤク ノ ヘイヨウ リョウホウ : ARB ト CCB ヘイヨウ ニ ヨル ゾウキ ホゴ コウカ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204430803072","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Anti-Atherosclerotic Potential of Dihydropyridine Calcium Channel Blockers"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204836578176","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"高血圧併用療法とCOPE Trial"},{"@language":"en","@value":"Evidence for the Treatment of Hypertension with Combination Therapy and the COPE Trial"},{"@language":"ja-Kana","@value":"コウケツアツ ヘイヨウ リョウホウ ト COPE Trial ミニ レビュー コニシショウ ジュショウシャ"},{"@value":"小西賞受賞者 高血圧併用療法とCOPE Trial"},{"@language":"ja-Kana","@value":"コニシショウ ジュショウシャ コウケツアツ ヘイヨウ リョウホウ ト COPE Trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205024221952","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"CKD"},{"@language":"ja","@value":"ＣＫＤ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205108490112","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Effect of Diuretic or Calcium-Channel Blocker Plus Angiotensin-Receptor Blocker on Diastolic Function in Hypertensive Patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205225495168","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Combination of Antihypertensive Therapy in The Elderly, Multicenter Investigation (CAMUI) Trial"},{"@value":"for the CAMUI investigatorsCombination of antihypertensive therapy in the elderly, multicenter investigation (CAMUI) trial: rationale and design."}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205225687808","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Prognostic Effects of Combined Treatment With Calcium Channel Blockers and Statins in Patients With Coronary Narrowing  From the Japanese Coronary Artery Disease Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205367420032","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"糖尿病とレニン・アンジオテンシン系抑制薬―レニン阻害薬を含めて―"},{"@language":"en","@value":"S10-5. Renin-Angiotensin Inhibitor against Diabetes Mellitus"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206443503104","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"1) Hypertension"},{"@language":"ja","@value":"1）高血圧"},{"@value":"高血圧"},{"@language":"ja-Kana","@value":"コウケツアツ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206443659008","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"2. Treatment of Complicated Hypertension. 2) Chronic Renal Disease."},{"@language":"ja","@value":"2）慢性腎臓病"},{"@value":"慢性腎臓病"},{"@language":"ja-Kana","@value":"マンセイ ジンゾウビョウ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206444864768","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"2) Hypertension"},{"@language":"ja","@value":"2）炎症と動脈硬化　高血圧"},{"@value":"炎症と動脈硬化 高血圧"},{"@language":"ja-Kana","@value":"エンショウ ト ドウミャク コウカ コウケツアツ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206446912128","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"2. Strategy for the Treatment of Hypertension in Chronic Kidney Disease, Focusing on Na Regulation"},{"@language":"ja","@value":"2．慢性腎臓病（CKD）における高血圧治療―Na調節を中心に―"},{"@value":"招請講演 慢性腎臓病(CKD)における高血圧治療 : Na調節を中心に"},{"@language":"ja-Kana","@value":"ショウセイ コウエン マンセイ ジンゾウビョウ(CKD)ニ オケル コウケツアツ チリョウ : Na チョウセツ オ チュウシン ニ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001277344927744","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Zhengganxifeng Decoction Affects Gut Microbiota and Reduces Blood Pressure <i>via</i> Renin–Angiotensin System"},{"@value":"Zhengganxifeng Decoction Affects Gut Microbiota and Reduces Blood Pressure via Renin-Angiotensin System"}]},{"@id":"https://cir.nii.ac.jp/crid/1390002184858743040","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Obesity-related hypertension and enhanced plasma orexin-A level are attenuated by the consumption of thiamine water in diabetic rats under cerebral oxidative stress conditions"}]},{"@id":"https://cir.nii.ac.jp/crid/1390005667265535616","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"An optimal medical therapy for efficient cardiovascular protection in subjects with coronary artery diseases in Japan: Comparisons and analyses by quasi-randomized controlled trials with propensity score matching and inverse probability treatment weighting methods for a Japanese cohort"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680078787840","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"How Controlling of Hypertension Might Matter"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681420376064","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"3. Clinical Implication of 24-hr Ambulatory Blood Pressure Monitoring."},{"@language":"ja","@value":"3．24時間血圧測定の必要性"},{"@value":"24時間血圧測定の必要性"},{"@language":"ja-Kana","@value":"24ジカン ケツアツ ソクテイ ノ ヒツヨウセイ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390564237989621248","@type":"Article","resourceType":"エディトリアル(editorial)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Targeting Vascular Inflammaging with Amlodipine for Atherosclerosis Prevention"}]},{"@id":"https://cir.nii.ac.jp/crid/1390572664475401088","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"JCS/JSCVS 2018 Guideline on Revascularization of Stable Coronary Artery Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1391131406293094272","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Diagnosis, Prevention, and Treatment of Cardiovascular Diseases in People With Type 2 Diabetes and Prediabetes　― A Consensus Statement Jointly From the Japanese Circulation Society and the Japan Diabetes Society ―"}]},{"@id":"https://cir.nii.ac.jp/crid/2050870367073818624","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Antihypertensive effect of a fixed-dose combination of losartan /hydrochlorothiazide in patients with uncontrolled hypertension : a multicenter study"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1056/nejmoa0806182"},{"@type":"CROSSREF","@value":"10.1007/s10157-017-1518-2_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1038/hr.2011.184_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1038/hr.2012.184_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1038/hr.2014.23_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1371/journal.pone.0082082_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1038/s41440-019-0284-9_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1161/hypertensionaha.119.13886_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1536/ihj.53.244_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.2169/naika.102.2169_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1254/fpj.139.246_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.3999/jscpt.41.61s_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.3143/geriatrics.47.540_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1007/s13340-020-00471-5_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1536/ihj.18-212_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1007/s10157-021-02153-1_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1038/hr.2010.233_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1038/hr.2011.178_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1038/hr.2012.110_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1038/hr.2013.10_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1371/journal.pone.0039162_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.3109/10641963.2012.681082_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-09-0808_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.2169/naika.98.2176_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-20-1282_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1038/hr.2014.166_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1007/s10157-011-0564-4_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.3109/10641963.2011.577487_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1007/s10557-011-6309-5_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1038/ajh.2012.26_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1093/ndt/gft034_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1583/13-4618r.1_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.3109/10641963.2011.583971_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-20-0865_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1016/j.amjmed.2011.12.010_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1161/hypertensionaha.111.189217_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1002/clc.20855_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1007/s13340-015-0206-2_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1038/hr.2014.130_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1097/hjh.0b013e328348345d_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1161/hypertensionaha.117.10238_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1586/erc.12.34_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1536/ihj.51.299_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.2169/naika.100.357_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.2169/naika.100.385_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.2169/naika.99.2096_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.5551/jat.12450_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1016/j.jash.2013.09.002_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.2131/fts.6.383_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1161/hypertensionaha.120.15154_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1111/1440-1681.13329_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1016/j.jash.2012.09.001_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1038/ki.2012.326_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1016/j.jash.2011.09.004_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.30548/vascfail.4.1_7_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1097/mbp.0000000000000172_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1097/maj.0000000000000529_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-15-0815_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.2342/ymj.64.17_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1097/hjh.0b013e328353f1fe_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1097/hjh.0b013e32835fdf60_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"},{"@type":"CROSSREF","@value":"10.1248/bpb.b19-00057_references_DOI_KL0glK9WOxFSTYplRBIVD2yP8on"}]}